Fineotex Chemical Limited announced the allotment of 50,00,000 equity shares following the conversion of 5,00,000 warrants. The conversion was approved by the Fund Raising Committee of the Board of Directors in a meeting held on January 17, 2026. These warrants were initially issued on a preferential basis at an issue price of ₹387.40 each. The allottees, belonging to the Non-Promoter Category, paid the balance amount of ₹290.55 per warrant, constituting 75% of the issue price, to exercise their conversion rights.

The issue price for the newly allotted equity shares is ₹38.74 each, including a premium of ₹37.74 per share. The company's paid-up capital has consequently increased to ₹116,45,00,900, comprising 116,45,00,900 equity shares of ₹1 each. The newly allotted shares will rank pari-passu with the existing equity shares. This adjustment in share capital reflects the company's share split and bonus issue approved at the Extraordinary General Meeting held on October 25, 2025.

The meeting of the Fund Raising Committee commenced at 03:00 pm and concluded at 03:30 pm on January 17, 2026. Out of the 28,15,049 convertible warrants initially allotted on July 19, 2024, 5,00,000 warrants have been exercised for conversion. The remaining 23,15,049 warrants, along with the received subscription amount of ₹22,42,12,496, stand forfeited as per SEBI regulations.